Albin JEANNE, PhD
CEO
Apmonia Therapeutics
Albin Jeanne, PhD, is CEO and co-founder of Apmonia Therapeutics. He has over 15 years of experience in biotechnology, company creation and drug development. He has led the development of Apmonia from early research to clinical stage, including fundraising, regulatory strategy and clinical development planning. He has raised more than €20M in equity and non-dilutive funding and is currently leading the company’s clinical development and strategic partnerships.
Sessions
-
23-Jun-20265BApmonia Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}